Filana Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -367 | |||
EBITDA | -13,185 | -11,729 | -45,174 | -24,366 |
EBIT | -13,552 | -11,860 | -45,392 | -24,586 |
Net Income | -12,539 | -10,807 | -44,224 | -23,403 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,249 | -6,301 | -4,947 | -11,336 |
Cash | 95,502 | 106,080 | 112,381 | 117,328 |
Basic Shares | 48,308 | 48,308 | 48,308 | 48,262 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -936 | |||
EBITDA | -94,454 | -141,146 | -105,803 | -80,181 |
EBIT | -95,390 | -142,278 | -107,333 | -81,482 |
Net Income | -90,973 | -24,342 | -97,217 | -76,246 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -32,833 | -117,032 | -82,439 | -80,226 |
Cash | 95,502 | 128,574 | 121,136 | 201,015 |
Basic Shares | 48,297 | 4,660,400 | 41,932 | 40,202 |
